Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
International Journal of Environmental Research and Public Health|February 26, 2014
Exploring powered wheelchair users and their caregivers' perspectives on potential intelligent power wheelchair use: a qualitative studyDahlia Kairy, Paula W Rushton, Philippe Archambault, et al.Disability and Rehabilitation. Assistive Technology|April 10, 2014
The potential impact of intelligent power wheelchair use on social participation: perspectives of users, caregivers and cliniciansPaula W Rushton, Dahlia Kairy, Philippe Archambault, et al.Journal of Diabetes Science and Technology|August 9, 2025
Miniaturized Neural Networks for Deploying Fully Closed Loop Insulin Delivery Systems: A Pilot Study Featuring Flexible Meal Announcement OptionsElliott C Pryor, Marcela Moscoso-Vasquez, David Fulkerson, et al.Diabetes, Obesity & Metabolism|May 28, 2021
Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studiesMichael A Tsoukas, Elisa Cohen, Laurent Legault, et al.Diabetes, Obesity & Metabolism|February 2, 2021
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trialAhmad Haidar, Jean-Francois Yale, Leif Erik Lovblom, et al.Diabetes Research and Clinical Practice|December 11, 2025
Human factors in the use and efficacy of decision support technologies for type 1 diabetes: evidence from a randomized controlled trialJacopo Pavan, Ralf Nass, Chiara Fabris, et al.Diabetologia|December 15, 2025
Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetesAlessandra Kobayati, Michael A Tsoukas, Natasha Garfield, et al.Diabetes Technology & Therapeutics|February 6, 2026
Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled TrialAnas El Fathi, Ralf Nass, Carol J Levy, et al.Pageof 3